Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial – The Lancet Respiratory Medicine Commentary: PRINCIPLE: a community-based COVID-19 platform trial – The Lancet Respiratory Medicine   Commentary on Twitter NEW Research—In suspected #COVID19 in the community, doxycycline […]

The post PRINCIPLE RCT: Doxycycline does not improve outcomes in outpatients with suspected COVID-19 at high risk for adverse outcomes. appeared first on Links Medicus.